1. World Health Organization . Weekly Epidemiological Update: Coronavirus Disease 2019 (COVID-19) 10 November 2020. World Health Organization; 2020.
Google Scholar2. Huang, I, Lim, MA, Pranata, R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr Clin Res Rev. 2020;14:395-403.
Google Scholar | Crossref | Medline3. Pranata, R, Huang, I, Lim, MA, Wahjoepramono, EJ, July, J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19–systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020;29:104949.
Google Scholar | Crossref | Medline4. Pranata, R, Permana, H, Huang, I, et al. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Diabetes Metab Syndr Clin Res Rev. 2020;14:983-990.
Google Scholar | Crossref | Medline5. Pranata, R, Lim, MA, Huang, I, Raharjo, SB, Lukito, AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin Angiotensin Aldosterone Syst. 2020;21:147032032092689.
Google Scholar | SAGE Journals6. Pranata, R, Lim, MA, Yonas, E, et al. Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis. Diabetes Metab. Published online July 29, 2020. doi:10.1016/j.diabet.2020.07.005
Google Scholar | Crossref7. Huang, I, Pranata, R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care. 2020;8:36.
Google Scholar | Crossref | Medline8. Lim, MA, Pranata, R, Huang, I, et al. Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis. Can J Kidney Heal Dis. 2020; 7: 205435812093857.
Google Scholar | Medline9. Pranata, R, Huang, I, Lukito, AA, et al. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Postgrad Med J. Published online May 20, 2020. doi:10.1136/postgradmedj-2020-137884
Google Scholar | Crossref10. Garcez, MR, Pereira, JL, Fontanelli, M, Marchioni, DM, Fisberg, RM. Prevalence of dyslipidemia according to the nutritional status in a representative sample of São Paulo. Arq Bras Cardiol. 2014;103:476-484.
Google Scholar | Medline11. Goff, DC, Bertoni, AG, Kramer, H, et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation. 2006;113:647-656.
Google Scholar | Crossref | Medline | ISI12. Opoku, S, Gan, Y, Fu, W, et al. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP). BMC Public Health. 2019;19:1500. doi:10.1186/s12889-019-7827-5
Google Scholar | Crossref | Medline13. Zhang, C, Qin, L, Li, K, et al. A novel scoring system for prediction of disease severity in COVID-19. Front Cell Infect Microbiol. Published online June 5, 2020. doi:10.3389/fcimb.2020.00318
Google Scholar | Crossref14. Chen, Q, Zheng, Z, Zhang, C, et al. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection. 2020;48:543-551.
Google Scholar | Crossref | Medline15. Zhang, JJ, Dong, X, Cao, YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy Eur J Allergy Clin Immunol. 2020;75:1730-1741.
Google Scholar | Crossref16. Petrilli, CM, Jones, SA, Yang, J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi:10.1136/bmj.m1966
Google Scholar | Crossref | Medline17. Choi, GJ, Kim, HM, Kang, H. The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews. J Lipid Atheroscler. 2020;9:435.
Google Scholar | Crossref | Medline18. Hwang, JM, Kim, JH, Park, JS, et al. Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study. Neurol Sci. 2020;41:2317-2324.
Google Scholar | Crossref | Medline19. Santos, CS, Morales, CM, Álvarez, ED, et al. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol. 2020;39:2789-2796.
Google Scholar | Crossref | Medline20. Simonnet, A, Chetboun, M, Poissy, J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28:1195-1199.
Google Scholar | Crossref | Medline21. To, KKW, Tsang, OTY, Leung, WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565-574.
Google Scholar | Crossref | Medline22. Chang, MC, Park, YK, Kim, BO, et al. Risk factors for disease progression in COVID-19 patients. BMC Infect Dis. 2020;20:4-9.
Google Scholar | Crossref | Medline23. Kow, CS, Hasan, SS. Meta-analysis of effect of statins in patients with COVID-19. Am J Cardiol. 2020;134:153-155.
Google Scholar | Crossref | Medline24. Chen, VL, Hawa, F, Berinstein, JA, et al. Hepatic steatosis is associated with increased disease severity and liver injury in coronavirus disease-19. Dig Dis Sci. Published online September 27, 2020. doi:10.1007/s10620-020-06618-3
Google Scholar | Crossref25. Kim, T, Roslin, M, et al. Body mass index as a risk factor for clinical outcomes in patients hospitalized with COVID-19 in New York. Obesity. Published online November 11, 2020. doi:10.1002/oby.23076
Google Scholar | Crossref26. Lim, MA, Huang, I, Yonas, E, et al. A wave of non-communicable diseases following the COVID-19 pandemic. Diabetes Metab Syndr Clin Res Rev. 2020;14:979-980.
Google Scholar | Crossref | Medline27. Lim, MA, Pranata, R. Sports activities during any pandemic lockdown. Irish J Med Sci (1971 -). Published online July 4, 2020. doi:10.1007/s11845-020-02300-9
Google Scholar | Crossref28. Lim, MA. Exercise addiction and COVID-19-associated restrictions. J Ment Heal. Published online August 5, 2020. doi:10.1080/09638237.2020.1803234
Google Scholar | Crossref29. Yonas, E, Alwi, I, Pranata, R, et al. Effect of heart failure on the outcome of COVID-19 — A meta analysis and systematic review. Am J Emerg Med. Published online July 9, 2020. doi:10.1016/j.ajem.2020.07.009
Google Scholar | Crossref30. Pranata, R, Soeroto, AY, Ian, H, et al. Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19. Int J Tuberc Lung Dis. 2020;24:838-843. doi:10.5588/ijtld.20.0278
Google Scholar | Crossref | Medline31. Lim, MA, Pranata, R. The importance of COVID-19 prevention and containment in hemodialysis unit. Clin Med Insights Circ Respir Pulm Med. 2020;14:1179548420939256.
Google Scholar | SAGE Journals32. Pranata, R, Supriyadi, R, Huang, I, et al. The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-analysis. Clin Med Insights Circ Respir Pulm Med. Published online September 2020;14. doi:10.1177/1179548420959165
Google Scholar | SAGE Journals33. Lim, MA, Pranata, R. Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture – a systematic review and meta-analysis. J Clin Orthop Trauma. Published online September 17, 2020. doi:10.1016/j.jcot.2020.09.015
Google Scholar | Crossref34. Huang, I, Pranata, R, Lim, MA, et al. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14:175346662093717.
Google Scholar | SAGE Journals35. Sorokin, AV, Karathanasis, SK, Yang, Z-H, et al. COVID-19-Associated dyslipidemia: implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. 2020;34:9843-9853. doi:10.1096/fj.202001451
Google Scholar | Crossref | Medline36. Barter, PJ, Nicholls, S, Rye, KA, et al. Antiinflammatory properties of HDL. Circ Res. 2004;95:764-772.
Google Scholar | Crossref | Medline | ISI37. Feingold, KR, Krauss, RM, Pang, M, et al. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab. 1993;76:1423-1427.
Google Scholar | Medline | ISI38. Van Lenten, BJ, Wagner, AC, Nayak, DP, et al. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation. 2001;103:2283-2288.
Google Scholar | Crossref | Medline | ISI39. Hu, X, Chen, D, Wu, L, et al. Low serum cholesterol level among patients with COVID-19 infection in Wenzhou, China. China. 2020.
Google Scholar40. Wei, X, Zeng, W, Su, J, et al. Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol. 2020;14:297-304.
Google Scholar | Crossref | Medline41. Khovidhunkit, W, Kim, M-S, Memon, RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45:1169-1196.
Google Scholar | Crossref | Medline | ISI42. Farid, AS, Horii, Y. Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis. Lipids Health Dis. 2012;11:92.
Google Scholar | Crossref | Medline43. Ryoo, S, Bhunia, A, Chang, F, et al. OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis. 2011;214:279-287.
Google Scholar | Crossref | Medline | ISI44. Stancel, N, Chen, C-C, Ke, L-Y, et al. Interplay between CRP, Atherogenic LDL, and LOX-1 and its potential role in the pathogenesis of atherosclerosis. Clin Chem. 2016;62:320-327.
Google Scholar | Crossref | Medline45. Erol, A. Role of oxidized LDL-induced “trained macrophages” in the pathogenesis of COVID-19 and benefits of pioglitazone: a hypothesis. Diabetes Metab Syndr Clin Res Rev. 2020;14:713-714.
Google Scholar | Crossref | Medline46. Daniels, LB, Sitapati, AM, Zhang, J, et al. Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients. Am J Cardiol. 2020;136:149-155. doi:10.1016/j.amjcard.2020.09.012
Google Scholar | Crossref | Medline47. Pranata, R, Lim, MA, Yonas, E, et al. Out-of-hospital cardiac arrest prognosis during the COVID-19 pandemic. Intern Emerg Med. Published online November 14, 2020;15. doi:10.1007/s11739-020-02428-7
Google Scholar | Crossref | Medline48. July, J, Pranata, R. Impact of the coronavirus disease pandemic on the number of strokes and mechanical thrombectomies: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2020;29:105185. doi:10.1016/j.jstrokecerebrovasdis.2020.105185
Google Scholar | Crossref | Medline